Topic Archives: INmune Bio (INMB)


  • In your past newsletter, I read aboutINmune Bio, Inc.(NASDAQ: INMB) , a clinical-stage immunology company focused on dev...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info